Skip to main content
. 2014 Feb 28;9(2):e90150. doi: 10.1371/journal.pone.0090150

Table 1. Main characteristics of subjects.

Healthy controls COPD COPDND COPDD
N (M/F) 15 (9/6) 28 (16/12) 15 (9/6) 13 (7/6)
Age, y 65±6 65±7 66±7 65±6
Height, cm 170±11 169±9 168±7 169±11
Weight, kg 72±12 71±10 74±10 67±10
BMI, kg/m 24.9±3.3 25.1±2.8 26.4±2.5 23.5±2.3#
FFMI, kg/m 18.0±1.9 17.5±1.8 18.0±2.0 16.9±1.5
Smoking status current/former/never 1/7/7 10/18/0** 7/8/0** 3/10/0*
FEV1, % predicted 113±15 59±16*** 61±13*** 56±19***
FVC, % predicted 120±17 104±22* 98±20* 110±24
D L,CO, % predicted 95±19 51±16*** 55±16*** 47±16***
S p,o 2 at rest, % 98 (98, 100) 96 (95, 97)*** 97 (96, 97)*** 95 (94, 98)***
P a,o 2 at rest, kPa 12.1±1.1 9.3±1.0*** 9.5±0.8*** 9.1±1.2***
P a,co 2 at rest, kPa 5.3±0.2 5.2±0.5 5.1±0.5 5.2±0.4
Daily physical activity, counts/min 328 (276, 489) 214 (129, 300)** 208 (140, 278)** 220 (108, 366)

Values are expressed as mean±SD or median (25th percentile, 75th percentile). Abbreviations: BMI, body mass index; FFMI, fat-free mass index; FEV1, forced expiratory volume in one second; FVC, forced vital capacity; D L,CO, diffusion capacity of the lungs for carbon monoxide; Sp,o 2, oxygen saturation measured via pulse oximetry. Significance of difference compared to controls: *p<0.05, **p<0.01, ***p≤0.001. Level of significance COPDD vs. COPDND patients: #p<0.05.